THC metabolite alone proves cannabis use in legal testing

This forensic study challenges how cannabis use is detected and interpreted in hair samples, which are commonly used in legal and monitoring contexts. Traditional testing relies on THC detection, but this research demonstrates that detecting THC-COOH (the primary THC metabolite) alone—without THC—is valid evidence of cannabis use. The study analyzed 639 hair samples from individuals monitored for driving license reinstatement, finding that 76 samples tested positive for THC-COOH only, not just THC and THC-COOH together. Importantly, wash tests confirmed these THC-COOH-only cases originated from actual cannabis use, not external contamination, settling a major interpretative challenge in forensic analysis.

The research reveals important segmental patterns in cannabinoid distribution: THC, CBD, CBN, and THC-COOH concentrations were significantly higher in proximal hair (0-3 cm, closest to the scalp) than in distal segments, reflecting more recent use. This finding helps forensic experts distinguish between active use and past exposure. When researchers incorporated THC-COOH-only positive cases into their analysis, agreement with self-reported cannabis use improved substantially (correlation up to 0.54), demonstrating that treating THC-COOH as a standalone primary marker—rather than requiring both compounds to be present—provides more accurate abstinence monitoring.

For cannabis users and the broader scientific community, these findings have significant practical implications. Hair testing guidelines should recognize THC-COOH as a valid and independent marker of cannabis use, not merely a supplementary confirmation. This is particularly important in legal, employment, and clinical settings where hair testing determines consequences like license reinstatement or custody decisions. The multi-matrix approach combining hair, blood, and urine samples, along with improved understanding of THC-COOH behavior, strengthens the reliability of cannabis detection protocols and supports more accurate interpretation of borderline or ambiguous results.